Pretreatment With Toll-like Receptor 4 Antagonist Inhibits Lipopolysaccharide-Induced Preterm Uterine Contractility, Cytokines, and Prostaglandins in Rhesus Monkeys
- 1 February 2008
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 15 (2) , 121-127
- https://doi.org/10.1177/1933719107310992
Abstract
Intrauterine infection, which occurs in most early preterm births, triggers an immune response culminating in preterm labor. The authors hypothesize that blockade of lipopolysaccharide (LPS)—induced immune responses by a toll-like receptor 4 antagonist (TLR4A) would prevent elevations in amniotic fluid (AF) cytokines, prostaglandins, and uterine contractility. Chronically catheterized rhesus monkeys at 128 to 147 days' gestation received intra-amniotic infusions of either (1) saline (n = 6), (2) LPS (0.15-10 µg; n = 4), or (3) TLR4A pretreatment with LPS (10 µg) 1 hour later (n = 4). AF cytokines, prostaglandins, and uterine contractility were compared using 1-way ANOVA with Bonferroniadjusted pairwise comparisons. Compared with saline controls, LPS induced significant elevations in AF interleukin-8 (IL-8), tumor necrosis factor (TNF)— α, PGE2, PGF2α, and uterine contractility (P < .05). In contrast, TLR4A pretreatment inhibited LPS-induced uterine activity and was associated with significantly lower AF IL-8, TNF-α, PGE2, and PGF2 αversus LPS alone (P < .05). Toll-like receptor antagonists, together with antibiotics, may delay or prevent infection-associated preterm birth.Keywords
This publication has 38 references indexed in Scilit:
- Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate modelAmerican Journal of Obstetrics and Gynecology, 2007
- LPS Induces Translocation of TLR4 in Amniotic EpitheliumPlacenta, 2006
- Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitisAmerican Journal of Obstetrics and Gynecology, 2004
- Extended in Vivo Pharmacodynamic Activity of E5564 in Normal Volunteers with Experimental EndotoxemiaThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Human macrophage activation programs induced by bacterial pathogensProceedings of the National Academy of Sciences, 2002
- Afferent Pathways of Pyrogen SignalingaAnnals of the New York Academy of Sciences, 1998
- Tolerance to lipopolysaccharide is not related to the ability of the hypothalamus to produce prostaglandin E2Life Sciences, 1997
- Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.Journal of Clinical Investigation, 1990
- A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in PrematurityNew England Journal of Medicine, 1988
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982